Citadel Advisors
POTX

Citadel Advisors’s Global X Cannabis ETF POTX Stock Holding History

Citadel Advisors’s Portfolio POTX Stock Details POTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,797
Closed -$22.2K – 15886
2023
Q4 		$22.2K Sell
3,797
-911
-19% -$5.19K ﹤0.01% 12535
2023
Q3 		$31.3K Sell
4,708
-2,389
-34% -$16.6K ﹤0.01% 12235
2023
Q2 		$45.3K Sell
7,097
-3,465
-33% -$27.4K ﹤0.01% 11920
2023
Q1 		$96K Buy
10,562
+4,881
+86% +$53.5K ﹤0.01% 11325
2022
Q4 		$63.2K Sell
5,681
-16,559
-74% -$235K ﹤0.01% 11850
2022
Q3 		$305K Buy
+22,240
New +$374K ﹤0.01% 9550
2022
Q2 		– Sell
-8,246
Closed -$186K – 14825
2022
Q1 		$270K Sell
8,246
-11,184
-58% -$349K ﹤0.01% 10827
2021
Q4 		$678K Buy
19,430
+7,115
+58% +$337K ﹤0.01% 8914
2021
Q3 		$661K Buy
12,315
+97
+0.8% +$6.29K ﹤0.01% 9207
2021
Q2 		$1.01M Buy
12,218
+9,215
+307% +$791K ﹤0.01% 8351
2021
Q1 		$289K Buy
3,003
+1,145
+62% +$114K ﹤0.01% 10947
2020
Q4 		$111K Buy
+1,858
New +$107K ﹤0.01% 10164

Other funds holding POTX

WFS
Weitzel Financial Services Dubuque, Iowa $294M AUM 17.77% 1-Year Est. Return

Citadel Advisors's POTX Position: Q1 2024 in Review

Citadel Advisors sold out of Global X Cannabis ETF (POTX) in Q1 2024, closing a stake of 3,797 shares — an estimated $22.2K sold.

Citadel Advisors first reported a position in POTX in Q4 2020 and held it in 12 quarters. The position peaked at $1.01M in Q2 2021. 1 fund tracked by Wall St. Rank holds POTX as of Q1 2024.

  • Citadel Advisors reported no remaining Global X Cannabis ETF position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 3,797 Global X Cannabis ETF shares in Q1 2024, an estimated $22.2K.
  • Citadel Advisors first reported a position in Global X Cannabis ETF in Q4 2020 and held it in 12 quarters.
  • Citadel Advisors's Global X Cannabis ETF position peaked at $1.01M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Global X Cannabis ETF as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.